B
Betül Baykan
Researcher at Istanbul University
Publications - 257
Citations - 4569
Betül Baykan is an academic researcher from Istanbul University. The author has contributed to research in topics: Epilepsy & Migraine. The author has an hindex of 32, co-authored 224 publications receiving 3558 citations. Previous affiliations of Betül Baykan include Sapienza University of Rome & University Medical Center Utrecht.
Papers
More filters
Journal ArticleDOI
Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions
Hsien Yang Lee,Yong Huang,Yong Huang,Nadine Bruneau,Patrice Roll,Elisha D.O. Roberson,Mark Hermann,Emily Quinn,Emily Quinn,James W. Maas,Robert H. Edwards,Tetsuo Ashizawa,Betül Baykan,Kailash P. Bhatia,Susan B. Bressman,Michiko K. Bruno,Michiko K. Bruno,Ewout R. Brunt,Roberto Caraballo,Bernard Echenne,Natalio Fejerman,Steve Frucht,Christina A. Gurnett,Edouard Hirsch,Henry Houlden,Joseph Jankovic,Wei Ling Lee,David A. Lynch,Shehla Mohammed,Ulrich Müller,Mark Nespeca,David Renner,Jacques Rochette,Gabrielle Rudolf,Shinji Saiki,Bing-Wen Soong,Bing-Wen Soong,Kathryn J. Swoboda,Sam Tucker,Nicholas W. Wood,Michael G. Hanna,Anne M. Bowcock,Pierre Szepetowski,Ying-Hui Fu,Louis J. Ptáček,Louis J. Ptáček +45 more
TL;DR: Four truncating mutations involving the gene PRRT2 in the vast majority of well-characterized families with PKD/IC are identified, leading ultimately to neuronal hyperexcitability that manifests in vivo as PKd/IC.
Journal ArticleDOI
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy
Mikko Muona,Samuel F. Berkovic,Leanne M. Dibbens,Karen Oliver,Snezana Maljevic,Marta A. Bayly,Tarja Joensuu,Laura Canafoglia,Silvana Franceschetti,Roberto Michelucci,Salla Markkinen,Sarah E. Heron,Michael S. Hildebrand,Eva Andermann,Frederick Andermann,Antonio Gambardella,Paolo Tinuper,Laura Licchetta,Ingrid E. Scheffer,Ingrid E. Scheffer,Ingrid E. Scheffer,Chiara Criscuolo,Alessandro Filla,Edoardo Ferlazzo,Jamil Ahmad,Adeel Ahmad,Betül Baykan,Edith Said,Edith Said,Meral Topçu,Patrizia Riguzzi,Mary D. King,Mary D. King,Cigdem Ozkara,Danielle M. Andrade,Bernt A. Engelsen,Bernt A. Engelsen,Arielle Crespel,Matthias Lindenau,Ebba Lohmann,Ebba Lohmann,Veronica Saletti,João Massano,Michael Privitera,Alberto J. Espay,Birgit Kauffmann,Michael Duchowny,Michael Duchowny,Rikke S. Møller,Rachel Straussberg,Zaid Afawi,Zaid Afawi,Bruria Ben-Zeev,Bruria Ben-Zeev,Kaitlin E. Samocha,Mark J. Daly,Mark J. Daly,Steven Petrou,Steven Petrou,Holger Lerche,Aarno Palotie,Anna-Elina Lehesjoki +61 more
TL;DR: In insights into the molecular genetic basis of PME, the role of de novo mutations in this disease entity is shown and their phenotypic spectra are expanded.
Journal ArticleDOI
COVID-19 is a Real Headache!
TL;DR: It is concluded that as a common non‐respiratory symptom of COVID‐19, headache should not be overlooked, and its characteristics should be recorded with scrutiny.
Journal ArticleDOI
One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults
Mustafa Ertas,Betül Baykan,Elif Kocasoy Orhan,Mehmet Zarifoglu,Necdet Karli,Sabahattin Saip,Ayşe Emel Önal,Aksel Siva +7 more
TL;DR: The one-year prevalence of migraine estimated as 16.4% was similar or even higher than world-wide reported migraine prevalence figures and identical to a previous nation-wide study conducted in 1998, whereas the TTH prevalence was much lower using the same methodology with the ICHD-II criteria.
Journal ArticleDOI
Consensus on diagnosis and management of JME: From founder's observations to current trends.
Dorothée G.A. Kasteleijn-Nolst Trenité,Bettina Schmitz,Bettina Schmitz,Dieter Janz,Dieter Janz,Antonio V. Delgado-Escueta,Antonio V. Delgado-Escueta,Pierre Thomas,Pierre Thomas,Edouard Hirsch,Edouard Hirsch,Holger Lerche,Holger Lerche,Carol Camfield,Carol Camfield,Betül Baykan,Betül Baykan,Martha Feucht,Martha Feucht,Iris E. Martínez-Juárez,Iris E. Martínez-Juárez,Reyna M. Durón,Reyna M. Durón,Marco T. Medina,Marco T. Medina,Guido Rubboli,Guido Rubboli,Judith Jerney,Judith Jerney,Bruce P. Hermann,Bruce P. Hermann,Elza Márcia Targas Yacubian,Elza Márcia Targas Yacubian,Michael Koutroumanidis,Michael Koutroumanidis,U. Stephani,U. Stephani,Javier Salas-Puig,Javier Salas-Puig,Ronald C. Reed,Ronald C. Reed,Friedrich Woermann,Friedrich Woermann,Britta Wandschneider,Britta Wandschneider,Michelle Bureau,Michelle Bureau,Antonio Gambardella,Antonio Gambardella,Matthias J. Koepp,Matthias J. Koepp,P. Gelisse,P. Gelisse,Cardan Gurses,Cardan Gurses,Arielle Crespel,Arielle Crespel,Vi-Huong Nguyen-Michel,Vi-Huong Nguyen-Michel,Edoardo Ferlazzo,Edoardo Ferlazzo,T. Grisar,T. Grisar,Ingo Helbig,Ingo Helbig,Bobby P.C. Koeleman,Bobby P.C. Koeleman,Pasquale Striano,Pasquale Striano,Michael Trimble,Michael Trimble,Russel Buono,Russel Buono,Patrick Cossette,Patrick Cossette,Alfonso Represa,Alfonso Represa,Charlotte Dravet,Charlotte Dravet,Anna Serafini,Anna Serafini,Ivanka Savic Berglund,Ivanka Savic Berglund,Sanjay M. Sisodiya,Sanjay M. Sisodiya,Kazuhiro Yamakawa,Kazuhiro Yamakawa,P. Genton,P. Genton +88 more
TL;DR: Patients with JME require special management because their epilepsy starts in the vulnerable period of adolescence and, accordingly, they have lifestyle issues that typically increase the likelihood of seizures with poor adherence to antiepileptic drugs (AEDs).